Coda Octopus Group, Inc. CODA Total Liabilities Assumed in Business Combination

Total Liabilities Assumed in Business Combination at other companies

CG OncologyCGON

$307K—

CBAK Energy Technology, Inc.CBAT

$333.82K—

BioSig Technologies, Inc.STEX

$12.59M—

Coda Octopus Group, Inc.CODA

$394.93K-4.4%

Oruka Therapeutics, Inc.ORKA

$54K—

First Commonwealth FinancialFCF

$21.4M—

Other financials

Income statement

See full

Revenue$6.9M-1.6%

Gross profit$4.6M+1.8%

Operating income$1.8M+64.8%

Net income$1.7M+86.8%

EPS (diluted)$0.15+87.5%

Balance sheet

See full

Cash & equivalents$30.6M+25.2%

Total debt$384.6K-8.8%

Total equity$61.4M+9.9%

Total assets$67.3M+11.1%

Cash flow

See full

Operating cash flow$570.4K-61.0%

CapEx$121.3K+77.7%

Free cash flow$449.1K-67.8%

Valuation

See full

Market cap$110.21M+20.0%

Enterprise value$79.97M+17.9%

P/E22.3×-4.5×

P/S3.9×-0.1×

Profitability

See full

Gross margin66.8%-0.3pp

Operating margin20%+4.9pp

Net margin17.7%+2.6pp

FCF margin21.4%-2.3pp

Returns & leverage

See full

Return on equity8.4%+2.0pp

Debt / equity0×0.0×

Current ratio10.2×-0.8×

Where this comes from

Reported directly by Coda Octopus Group, Inc. in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation.

The official record: Coda Octopus Group, Inc.’s 10-K/A, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Coda Octopus Group, Inc.'s total liabilities assumed in business combination.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Coda Octopus Group, Inc.'s total liabilities assumed in business combination?: Coda Octopus Group, Inc. (CODA) reported total liabilities assumed in business combination of $394.93K in Q3 2025.
What does total liabilities assumed in business combination mean?: The total value of debt, obligations, and other liabilities taken on by the company as a result of acquiring another entity. This metric is vital for assessing the impact of inorganic growth strategies on the company's overall risk profile and balance sheet health. It reflects the long-term financial commitments inherited through strategic expansion.